This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
ARANOTE
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
Charles Ryan, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ESMO 2024
BCAN TT 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide - Abstract
May 28, 2013
Radiation therapy modalities in prostate cancer - Abstract
May 28, 2013
Bone metastases and bone loss medical treatment in prostate cancer patients - Abstract
May 28, 2013
Low-risk prostate cancer patients without visible tumor (T1c) on multiparametric MRI could qualify for active surveillance candidate even if they did not meet inclusion criteria of active surveillance protocol - Abstract
May 28, 2013
Focal ablation of prostate cancer: Four roles for magnetic resonance imaging guidance - Abstract
May 28, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) - Abstract
May 28, 2013
Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012 - Abstract
May 28, 2013
Metabolic and toxicological considerations of newly approved prostate cancer drugs - Abstract
May 28, 2013
Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone - Abstract
May 28, 2013
Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer - Abstract
May 27, 2013
Prostate and patient intrafraction motion: Impact on treatment time-dependent planning margins for patients with endorectal balloon - Abstract
May 27, 2013
Pelvic lymph node dissection during robot-assisted radical prostatectomy: Efficacy, limitations, and complications-A systematic review of the literature - Abstract
May 27, 2013
Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: Results from a randomised phase 3 study by the South European Uroncological Group - Abstract
May 27, 2013
Monitoring brain activation changes in the early postoperative period after radical prostatectomy using fMRI - Abstract
May 27, 2013
Prostatic swelling and shift during high-intensity focused ultrasound: Implication for targeted focal therapy - Abstract
May 27, 2013
The effect of anterior proton beams in the setting of a prostate-rectum spacer - Abstract
May 25, 2013
Necessity analysis of bone scan in patients with newly diagnosed prostate cancer - Abstract
May 25, 2013
High dose rate prostate brachytherapy - Abstract
May 25, 2013
Prostate cancer diagnosis: Multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--Prospective multicenter study - Abstract
May 24, 2013
5-Alpha reductase inhibitors in patients on active surveillance: Do the benefits outweigh the risk? - Abstract
May 24, 2013
Page 1143 of 1422
Start
Prev
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free